Safety, immunogenicity and pregnancy outcomes in mothers and infants after vaccination with an adenovirus-vector COVID-19 vaccine during pregnancy

COVID-19 during pregnancy can be associated with adverse pregnancy and infant outcomes. We assessed the safety, reactogenicity, and immunogenicity of maternal vaccination with Ad26.COV2.S COVID-19 vaccine and monitored serum and breast milk antibody levels in mothers and infants until 6 months post-...

Full description

Saved in:

Bibliographic Details
Published in:	Human vaccines & immunotherapeutics Vol. 21; no. 1; p. 2538340
Main Authors:	Aguilar, Gloria, Tapia-Calle, Gabriela, Robinson, Cynthia, Baron, Benoit, Lowson, David, Maximos, Bassem, Rezelj, Veronica V., de Groot, Anne Marit, Bet, Nicole, van Paassen, Vitalija, Le Gars, Mathieu, Struyf, Frank, Ruiz-Guiñazú, Javier
Format:	Journal Article
Language:	English
Published:	United States Taylor & Francis 01.12.2025 Taylor & Francis Group
Subjects:	Adenoviridae - genetics Adenovirus vectors Adult Antibodies, Neutralizing - blood Antibodies, Viral - analysis Antibodies, Viral - blood Coronavirus COVID-19 COVID-19 - immunology COVID-19 - prevention & control COVID-19 Vaccines - administration & dosage COVID-19 Vaccines - adverse effects COVID-19 Vaccines - immunology Female Humans Immunogenicity, Vaccine Infant Infant, Newborn Milk, Human - immunology neonates passive antibody transfer Pregnancy Pregnancy Complications, Infectious - immunology Pregnancy Complications, Infectious - prevention & control Pregnancy Outcome SARS-CoV-2 SARS-CoV-2 - immunology Vaccination Young Adult COVID-19 passive antibody transfer SARS-CoV-2 vaccine pregnancy Adenovirus vectors neonates
ISSN:	2164-5515, 2164-554X, 2164-554X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!